Business Segments · Net Sales

Greater China — Net Sales

Viatris Greater China — Net Sales increased by 18.7% to $680.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.4%, from $555.50M to $680.10M. Over 4 years (FY 2021 to FY 2025), Greater China — Net Sales shows relatively stable performance with a 1.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing market share or successful product adoption in China, while a decrease suggests competitive pressure or regulatory headwinds.

Detailed definition

Represents the total revenue generated from the sale of pharmaceutical products and services within the Greater China ge...

Peer comparison

Standard regional revenue reporting found in most multinational pharmaceutical companies.

Metric ID: vtrs_segment_greater_china_net_sales

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$550.30M$566.80M$503.80M$573.10M$548.30M$574.00M$505.80M$564.60M$532.10M$548.40M$515.30M$543.90M$539.40M$562.20M$522.30M$555.50M$588.90M$615.20M$572.90M$680.10M
QoQ Change+3.0%-11.1%+13.8%-4.3%+4.7%-11.9%+11.6%-5.8%+3.1%-6.0%+5.6%-0.8%+4.2%-7.1%+6.4%+6.0%+4.5%-6.9%+18.7%
YoY Change-0.4%+1.3%+0.4%-1.5%-3.0%-4.5%+1.9%-3.7%+1.4%+2.5%+1.4%+2.1%+9.2%+9.4%+9.7%+22.4%
Range$503.80M$680.10M
CAGR+4.6%
Avg YoY Growth+3.0%
Median YoY Growth+1.4%

Frequently Asked Questions

What is Viatris's greater china — net sales?
Viatris (VTRS) reported greater china — net sales of $680.10M in Q1 2026.
How has Viatris's greater china — net sales changed year-over-year?
Viatris's greater china — net sales increased by 22.4% year-over-year, from $555.50M to $680.10M.
What is the long-term trend for Viatris's greater china — net sales?
Over 4 years (2021 to 2025), Viatris's greater china — net sales has grown at a 1.3% compound annual growth rate (CAGR), from $2.21B to $2.33B.
What does greater china — net sales mean?
Total revenue earned from operations in the Greater China region.